ANJUM KHAN: Open Payments
NPI 1548651979 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$576 in 5 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $938 · 2025 $576
Food & beverage: $576
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $129 |
| Gilead Sciences, Inc. | 1 | $119 |
| QOL Medical, LLC | 1 | $102 |
| ALK-Abello, Inc | 1 | $80 |
Products named: CAPLYTA, Sucraid, Odactra.
Industry payments across IL — which companies pay providers there.
